SEC Company Response from Hoth Therapeutics, Inc. (HOTH) (CIK 0001711786) (RKTO) — Oct 23, 2019
Hoth Therapeutics, Inc. (HOTH) (CIK 0001711786)
Date: Oct. 23, 2019 · CIK: 0001711786 · Accession: 0001213900-19-020939
AI Filing Summary & Sentiment
File numbers found in text: 333-233954
Show Raw Text
CORRESP
1
filename1.htm
Hoth Therapeutics, Inc.
1 Rockefeller Plaza, Suite 1039
New York, New York 10020
October 23,
2019
VIA EDGAR
United States Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Attention:
Ada D. Sarmento
Christine Westbrook
Re:
Hoth Therapeutics, Inc.
Registration Statement on Form S-1
File No. 333-233954
Ms. Sarmento:
Pursuant to Rule
461 of the General Rules and Regulations under the Securities Act of 1933, as amended (the “Act”), Hoth Therapeutics,
Inc. (the “Company”) respectfully requests that the effective date of the registration statement referred to above
be accelerated so that it will become effective at 5:00 p.m., Eastern Daylight Time, on Friday, October 25, 2019, or as soon thereafter
as possible.
Please notify Richard
Friedman of Sheppard, Mullin, Richter & Hampton LLP, counsel to the Company, at (212) 634-3031 as soon as possible as
to the time the Registration Statement has been declared effective pursuant to this acceleration request.
Respectfully,
HOTH THERAPEUTICS, INC.
By:
/s/ Robb Knie
Name:
Robb Knie
Title:
Chief Executive Officer
-1-